Sagard Healthcare, HCRx to acquire royalty interest in Hemgenix

Hemgenix is a gene therapy that reduces the rate of abnormal bleeding in people with hemophilia B.

16 May 2023•2 mins read
LinkedInXEmail
LinkedInXEmail

Related articles